MiR-375, a microRNA related to diabetes

Gene

Volumn 533, Issue 1, 2014, Pages 1-4

  Li, Xueling ^a  

^a INNER MONGOLIA UNIVERSITY   (China)

Author keywords

Cells; Diabetes; Insulin; MiR 375; Pancreas

Indexed keywords

EXENDIN 4; HEPATOCYTE NUCLEAR FACTOR 6; INSULIN; MICRORNA 375; MTPN PROTEIN; NEUROGENIC DIFFERENTIATION FACTOR; NEUROGENIN 3; PHOSPHOINOSITIDE DEPENDENT PROTEIN KINASE 1; TRANSCRIPTION FACTOR PDX 1; UNCLASSIFIED DRUG;

CELL GROWTH; CELL PROLIFERATION; DIABETES MELLITUS; EMBRYONIC STEM CELL; ENDODERM; GENE CONTROL; GENE FUNCTION; HUMAN; INSULIN RELEASE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PANCREAS ISLET BETA CELL; PANCREAS ISLET CELL; PRIORITY JOURNAL; REGULATOR GENE; REVIEW;

Β-CELLS; 3′ UTRS; AIFM1; APOPTOSIS-INDUCING FACTOR, MITOCHONDRION-ASSOCIATED 1; BASIC HELIX-LOOP-HELIX; BHLH; CADM1; CAMP; CAV1; CAVEOLIN 1; CELL ADHESION MOLECULE 1; CLQBP; COMPLEMENT COMPONENT 1, Q SUBCOMPONENT BINDING PROTEIN; CYCLIC ADENOSINE MONOPHOSPHATE; DIABETES; EEFLE1; ELAV (EMBRYONIC LETHAL, ABNORMAL VISION, DROSOPHILA)-LIKE 4; EPAC2; EUKARYOTIC TRANSLATION ELONGATION FACTOR 1 EPSILON 1; EXCHANGE PROTEIN ACTIVATED BY CYCLIC AMP 2; GEF II; GLP-1; GLUCAGON-LIKE PEPTIDE-1; GUANINE NUCLEOTIDE EXCHANGE FACTOR II; HEPATOCYTE NUCLEAR FACTOR 1BETA; HESCS; HNF1Β; HUD; HUMAN EMBRYONIC STEM CELLS; ID3; INDUCED PLURIPOTENT STEM CELLS; INHIBITOR OF DNA BINDING 3; INSM1; INSULIN; INSULINOMA-ASSOCIATED PROTEIN 1; IPSCS; MICRORNA; MIR-375; MIRNAS; MTPN; MYOTROPHIN; NEUROGENIN 3; NGN3; PAIRED BOX GENE 6; PANCREAS; PANCREATIC AND DUODENAL HOMEOBOX 1; PAX6; PDK1; PDX1; PKA; PROTEIN KINASE A; PYRUVATE DEHYDROGENASE KINASE, ISOZYME 1; RAS, DEXAMETHASONE-INDUCED 1; RASD1; REGULATOR OF G-PROTEIN SIGNALING 16; RGS16; SMARCA2; SOX; SRY (SEX DETERMINING REGION Y)-BOX; SWI/SNF RELATED MATRIX ASSOCIATED, ACTIN DEPENDENT REGULATOR OF CHROMATIN, SUBFAMILY A, MEMBER 2; THE 3′ UNTRANSLATED REGIONS; WHO; WORLD HEALTH ORGANIZATION;

CELL DIFFERENTIATION; DIABETES MELLITUS; EMBRYONIC STEM CELLS; HUMANS; INSULIN; ISLETS OF LANGERHANS; MICRORNAS;

EID: 84887240183     PISSN: 03781119     EISSN: 18790038     Source Type: Journal    
DOI: 10.1016/j.gene.2013.09.105     Document Type: Review

References (47)

1. Alvarez-Garcia I., Miska E.A. MicroRNA functions in animal development and human disease. Development 2005, 132(21):4653-4662. (Nov).
2. Avnit-Sagi T., Kantorovich L., Kredo-Russo S., Hornstein E., Walker M.D. The promoter of the pri-miR-375 gene directs expression selectively to the endocrine pancreas. PLoS One 2009, 4:e5033.
3. Baek D., Villén J., Shin C., Camargo F.D., Gygi S.P., Bartel D.P. The impact of microRNAs on protein output. Nature 2008, 455:64-71.
4. Ballian N., Brunicardi F.C. Islet vasculature as a regulator of endocrine pancreas function. World J. Surg. 2007, 31:705-714.
5. Bartel D.P. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004, 116(2):281-297. (Jan 23).
6. Calin G.A., et al. Frequent deletions and down-regulation of micro-RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. Proc. Natl. Acad. Sci. U. S. A. 2002, 99(24):15524-15529. (Nov 26, Epub 2002 Nov 14).
7. Chen B.Z., et al. Identification of microRNAs expressed highly in pancreatic islet-like cell clusters differentiated from human embryonic stem cells. Cell Biol. Int. 2011, 35(1):29-37. (Jan). 10.1042/CBI20090081.
8. Couzin J. MicroRNAs make big impression in disease after disease. Science 2008, 19:1782-1784.
9. D'Amour K.A., et al. Production of pancreatic hormone-expressing endocrine cells from human embryonic stem cells. Nat. Biotechnol. 2006, 24:1392-1401.
10. Dumortier O., Van Obberghen E. MicroRNAs in pancreas development. Diabetes Obes. Metab. 2012, 14(Suppl. 3):22-28. (Oct).
11. Duroux-Richard I., et al. MicroRNAs as new player in rheumatoid arthritis. Joint Bone Spine 2011, 78:17-22.
12. El Ouaamari A., Baroukh N., Martens G.A., Lebrun P., Pipeleers D., van Obberghen E. miR-375 targets 3-phosphoinositide-dependent proteinkinase-1 and regulates glucose-induced biological responses in pancreatic beta-cells. Diabetes 2008, 57:2708-2717.
13. Eng J. Exendin peptides. Mt Sinai J. Med. 1992, 59:147-149.
14. Enright A.J., John B., Gaul U., Tuschl T., Sander C., Marks D.S. MicroRNA targets in Drosophila. Genome Biol. 2003, 5(1):R1. (Epub 2003 Dec 12).
15. Goke R., et al. Exendin-4 is a high potency agonist and truncated exendin-(9-39) amide an antagonist at the glucagon-like peptide 1-(7-36) amide receptor of insulin-secreting beta-cells. J. Biol. Chem. 1993, 268:19650-19655.
16. Hahn von Dorsche H., Reiher H., Hahn H.J. Phases in the early development of the human islet organ. Anat. Anz. 1988, 166(1-5):69-76.
17. Hinton A., et al. A distinct microRNA signature for definitive endoderm derived from human embryonic stem cells. Stem Cells Dev. 2010, 19(6):797-807. (Jun). 10.1089/scd.2009.0224.
18. Hosoya M. Preparation of pancreatic β-cells from human iPS cells with small molecules. Islets 2012, 4(3):249-252. (May-Jun, Epub 2012 May 1). 10.4161/isl.20856.
19. Jhala U.S., et al. cAMP promotes pancreatic β-cell survival via CREB-mediated induction of IRS2. Genes Dev. 2003, 17:1575-1580.
20. Jiang J., et al. Generation of insulin-producing islet-like clusters from human embryonic stem cells. Stem Cells 2007, 25:1940-1953.
21. Jiang W., et al. In vitro derivation of functional insulin-producing cells from human embryonic stem cells. Cell Res. 2007, 17:333-344.
22. Jing D., Yan M. MicroRNAs and diabetes. Chin. J. Diabetes 2010, 18(7):548-550.
23. Joglekar M.V., Joglekar V.M., Hardikar A.A. Expression of islet-specific microRNAs during human pancreatic development. Gene Expr. Patterns 2009, 9:109-113.
24. Kapsimali M., Kloosterman W.P., de Bruijn E., Rosa F., Plasterk R.H., Wilson S.W. MicroRNAs show a wide diversity of expression profiles in the developing and mature central nervous system. Genome Biol. 2007, 8:R173.
25. Keller D.M., et al. Characterization of pancreatic transcription factor Pdx-1 binding sites using promoter microarray and serial analysis of chromatin occupancy. J. Biol. Chem. 2007, 282:32084-32092.
26. Keller D.M., Clark E.A., Goodman R.H. Regulation of microRNA-375 by cAMP in pancreatic β-cells. Mol. Endocrinol. 2012, 26(6):989-999. (Jun). 10.1210/me.2011-1205. Epub 2012 Apr 25.
27. Kim N., Kim H., Jung I., Kim Y., Kim D., Han Y.M. Expression profiles of miRNAs in human embryonic stem cells during hepatocyte differentiation. Hepatol. Res. 2011, 41(2):170-183. (Feb). 10.1111/j.1872-034X.2010.00752.x.
28. Kloosterman W.P., Lagendijk A.K., Ketting R.F., et al. Targeted inhibition of miRNA maturation with morpholinos reveals a role for miR-375 in pancreatic islet development. PLoS Biol. 2007, 5:e203.
29. Lewis B.P., Shih I.H., Jones-Rhoades M.W., Bartel D.P., Burge C.B. Prediction of mammalian microRNA targets. Cell 2003, 115(7):787-798. (Dec 26).
30. Lovis P., Gattesco S., Regazzi R. Regulation of the expression of components of the exocytotic machinery of insulin-secreting cells by microRNAs. Biol. Chem. 2008, 389:305-312.
31. Lyttle B.M., et al. Transcription factor expression in the developing human fetal endocrine pancreas. Diabetologia 2008, 51(7):1169-1180.
32. Micallef S.J., et al. INS(GFP/w) human embryonic stem cells facilitate isolation of in vitro derived insulin-producing cells. Diabetologia 2012, 55(3):694-706. (Mar).
33. Nostro M.C., et al. Stage-specific signaling through TGFbeta family members and WNT regulates patterning and pancreatic specification of human pluripotent stem cells. Development 2011, 138:861-871.
34. Pasquinelli A.E., Hunter S., Bracht J. MicroRNAs: a developing story. Curr. Opin. Genet. Dev. 2005, 15(2):200-205. (Apr).
35. Poy M.N., et al. A pancreatic islet-specific microRNA regulates insulin secretion. Nature 2004, 432(7014):226-230. (Nov 11).
36. Poy M.N., et al. miR-375 maintains normal pancreatic alpha- and beta-cell mass. Proc. Natl. Acad. Sci. U. S. A. 2009, 106:5813-5818.
37. Rafiq I., da Silva Xavier G., Hooper S., Rutter G.A. Glucose-stimulated preproinsulin gene expression and nuclear trans-location of pancreatic duodenum homeobox-1 require activation of phosphatidylinositol 3-kinase but not p38 MAPK/SAPK2. J. Biol. Chem. 2000, 275:15977-15984.
38. Saini H.K., Griffiths-Jones S., Enright A.J. Genomic analysis of human microRNA transcripts. Proc. Natl. Acad. Sci. U. S. A. 2007, 104:17719-17724.
39. Sarkar S.A., et al. Global gene expression profiling and histochemical analysis of the developing human fetal pancreas. Diabetologia 2008, 51(2):285-297.
40. Selbach M., Schwanhäusser B., Thierfelder N., Fang Z., Khanin R., Rajewsky N. Widespread changes in protein synthesis induced by microRNAs. Nature 2008, 455:58-63.
41. Shoback Greenspan's Basic & Clinical Endocrinology 2011, McGraw-Hill Medical, New York, (pp. Chapter 17). 9th ed. D.G. Gardner, Dolores (Eds.).
42. Speight J., Reaney M.D., Woodcock A.J., Smith R.M., Shaw J.A. Patient-reported outcomes following islet cell or pancreas transplantation (alone or after kidney) in type 1 diabetes: a systematic review. Diabet. Med. 2010, 27:812-822.
43. Stefani G., Slack F.J. Small non-coding RNAs in animal development. Nat. Rev. Mol. Cell Biol. 2008, 9:219-230.
44. Tang X., Tang G., Ozcan S. Role of microRNAs in diabetes. Biochim. Biophys. Acta 2008, 1779:697-701.
45. Wei R., et al. Dynamic expression of microRNAs during the differentiation of human embryonic stem cells into insulin-producing cells. Gene 2013, (Jan 29. pii: S0378-1119(13)00079-6, Epub ahead of print). 10.1016/j.gene.2013.01.038.
46. Wienholds E., et al. MicroRNA expression in zebrafish embryonic development. Science 2005, 309:310-311.
47. Zhang D., et al. Highly efficient differentiation of human ES cells and iPS cells into mature pancreatic insulin-producing cells. Cell Res. 2009, 19(4):429-438. (Apr). 10.1038/cr.2009.28.